Resonant Pharmaceuticals

Ahmedabad, India Founded: 2014 • Age: 12 yrs
Manufactures pharmaceutical products, offers research, consulting, and manufacturing services globally.

About Resonant Pharmaceuticals

Resonant Pharmaceuticals is a Healthcare company based in Ahmedabad (India) founded in 2014 by Jay Patel. It manufactures pharmaceutical products, offers research, consulting, and manufacturing services globally. It operates on a B2B model. The company has 69 employees. Its Indian entity Resonant Pharmaceuticals Private Limited reported revenue of β‚Ή14.67 Cr. Resonant Pharmaceuticals offers products and services including Pharmaceutical Products, Contract Analytical Research, and Consulting Services. Its focus areas include Pharmaceuticals, Manufacturing, Drug and Device Production and Biotech. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Resonant Pharmaceuticals, based in Ahmedabad, India, specializes in producing high-quality pharmaceutical products through advanced manufacturing and rigorous testing. They provide contract analytical research, consulting, and development of new medicines and devices, ensuring WHO-GMP compliance. The company focuses on regulatory approval, global reach, and customer satisfaction by meeting international standards and environmental practices.

  • Headquarters Ahmedabad, India
  • Employees 69
  • Founders Jay Patel
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website resonantpharma.com
  • Social LinkedIn
  • Legal Name Resonant Pharmaceuticals Private Limited
  • Date of Incorporation 26 Nov, 2014
  • Jurisdiction Navagam, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹14.67 Cr

    FY 2025 · +81% YoY

  • Net Loss
    -₹1.25 Cr

    FY 2025 · -8% margin

  • EBITDA
    ₹33.7 Lakh

    FY 2025 · 2% margin

  • Employee Count
    69

Products & Services of Resonant Pharmaceuticals

Resonant Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products, Contract Analytical Research, and Consulting Services.

Pharmaceutical Products
Manufacturing

Produces high-purity medicines and devices for global markets

Contract Analytical Research
Research Services

Offers testing and consulting for pharmaceutical development needs

Consulting Services
Regulatory Support

Provides expertise in regulatory compliance and product commercialization

Board of directors of Resonant Pharmaceuticals Private Limited (Resonant Pharmaceuticals)

Resonant Pharmaceuticals Private Limited is the primary company behind Resonant Pharmaceuticals. The board of Resonant Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Sagar Shashikant Shah, appointed in 2014.

DirectorDesignationAppointedTenureEntity
Sagar Shashikant Shah
DIN 07006690
Director26 Nov 201411 yrs 11 moResonant Pharmaceuticals Private Limited
Jay Dipak Patel
DIN 06995440
Director26 Nov 201411 yrs 11 moResonant Pharmaceuticals Private Limited
Ankit Deepak Bhargava
DIN 06625101
Director26 Nov 201411 yrs 11 moResonant Pharmaceuticals Private Limited
Birju Rajendra Shah
DIN 06378884
Director26 Nov 201411 yrs 11 moResonant Pharmaceuticals Private Limited

People of Resonant Pharmaceuticals

1 people are tracked at Resonant Pharmaceuticals (1 in leadership); the tracked headcount is 69.

NameRoleGroup
Founder, DirectorLeadership
Premium access

Complete people profiles for Resonant Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Resonant Pharmaceuticals

Figures of Resonant Pharmaceuticals Private Limited, the primary company behind Resonant Pharmaceuticals, for FY 2025. Revenue was ₹14.67 Cr (+81% year on year). Net loss was -₹1.25 Cr (-8% margin). EBITDA was ₹33.7 Lakh (2% margin). Revenue has grown at a compounded annual rate of +54% over three years and +69% over five years.

  • ₹14.67 CrRevenue · FY 2025 · +81% YoY
  • -₹1.25 CrNet loss · -8% margin
  • ₹33.7 LakhEBITDA · 2% margin
  • ₹5.00 CrPaid-up capital
  • 69Employees (provident fund records)
  • +54%Revenue CAGR, 3 years
  • +69%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Resonant Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Resonant Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Resonant Pharmaceuticals

Resonant Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Resonant Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Resonant Pharmaceuticals

The website of Resonant Pharmaceuticals (resonantpharma.com) receives about 1K visits a month.

  • Monthly visits
    1K

    ▲ 89.6% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Resonant Pharmaceuticals

Resonant Pharmaceuticals was founded in 2014.

Resonant Pharmaceuticals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Resonant Pharmaceuticals has 69 employees.

The primary company behind Resonant Pharmaceuticals, Resonant Pharmaceuticals Private Limited, reported revenue of β‚Ή14.67 Cr for FY 2025, up 81% year on year.

Resonant Pharmaceuticals, based in Ahmedabad, India, specializes in producing high-quality pharmaceutical products through advanced manufacturing and rigorous testing. They provide contract analytical research, consulting, and development of new medicines and devices, ensuring WHO-GMP compliance. The company focuses on regulatory approval, global reach, and customer satisfaction by meeting international standards and environmental practices.

Resonant Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Resonant Pharmaceuticals offers Pharmaceutical Products, Contract Analytical Research, and Consulting Services.

Resonant Pharmaceuticals operates through Resonant Pharmaceuticals Private Limited.

The legal entities of Resonant Pharmaceuticals currently have 4 directors, including Sagar Shashikant Shah, Jay Dipak Patel, Ankit Deepak Bhargava and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available